Compare AGCO Corporation (AGCO) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AGCO Corporation vs Centene Corp — how do they compare? AGCO Corporation trades at $102.25 (market cap $7.10B), while Centene Corp trades at $65.44 (market cap $32.05B). The key difference: Centene Corp is far larger — about 4.5× AGCO Corporation's market cap, and AGCO Corporation pays a 1.18% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| AGCO | CNC | |
|---|---|---|
Market Cap | $7.10B | $32.05B |
Sector | Industrials | Health |
52-Week High | $140.49 | $68.72 |
52-Week Low | $100.14 | $26.17 |
Enterprise Value | $9.37B | $21.10B |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.
Read more on AGCO →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
